CommercialPrior AuthHigh impact
Hematopoietic Cell Transplantation for Chronic Myeloid Leukemia
Blue Cross & Blue Shield of Mississippi·MS · Oncology, Hematology·Medical Policy
We identified it
Jun 20, 2026
Summary
Blue Cross Blue Shield of Mississippi updated their policy on hematopoietic cell transplantation for chronic myeloid leukemia. The policy requires prior authorization through Case Management for all covered transplant procedures and considers allogeneic HCT medically necessary under specific conditions while deeming autologous HCT investigational.
Action Required
Immediately: Billing team must ensure all hematopoietic cell transplantation procedures for chronic myeloid leukemia patients receive prior authorization through Case Management before scheduling. Update system to flag these procedures as requiring prior auth. Claims will be denied without proper authorization.